Published in Diabetes Care on July 01, 1996
Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care (2008) 2.14
Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes (2010) 1.80
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag (2010) 1.24
Reduced physical activity level and cardiorespiratory fitness in children with chronic diseases. Eur J Pediatr (2010) 1.00
Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetes. J Cardiometab Syndr (2009) 0.97
Severe hypoglycemia and cardiovascular disease incidence in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care (2012) 0.96
Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC. Diabetes (2013) 0.96
QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications study. Diabetes Care (2011) 0.95
Type 1 diabetes and cardiovascular disease. Cardiovasc Diabetol (2013) 0.94
A personalized approach to exercise promotion in adolescents with type 1 diabetes. Pediatr Diabetes (2009) 0.93
Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS). Diabetologia (2008) 0.92
Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia (2012) 0.90
Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia (2012) 0.90
Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes. Diabetes Metab J (2016) 0.89
Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study. Cardiovasc Diabetol (2015) 0.85
Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study. Cardiovasc Diabetol (2015) 0.84
Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK. Br J Pharmacol (2008) 0.82
Development of a coronary heart disease risk prediction model for type 1 diabetes: the Pittsburgh CHD in Type 1 Diabetes Risk Model. Diabetes Res Clin Pract (2010) 0.82
Predicting major outcomes in type 1 diabetes: a model development and validation study. Diabetologia (2014) 0.79
Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population. Exp Diabetes Res (2012) 0.78
Early aggressive macrovascular disease and type 1 diabetes mellitus without chronic complications: a case report. BMC Res Notes (2013) 0.77
Autoimmune-mediated vascular injury occurs prior to sustained hyperglycemia in a murine model of type I diabetes mellitus. J Surg Res (2011) 0.77
Arterial stiffness, lipoprotein particle size, and lipoprotein particle concentration in children with type 1 diabetes. J Pediatr Endocrinol Metab (2010) 0.76
Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia (2014) 0.75
Are young age and insulin treatment enough to diagnose IDDM? Diabetes Care (1997) 0.75
An update on the potential role of C-peptide in diabetes and osteoporosis. Endocrine (2017) 0.75
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care (2000) 9.10
Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey. BMJ (1997) 5.29
Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia (2001) 4.22
Increases in platelet and red cell counts, blood viscosity, and arterial pressure during mild surface cooling: factors in mortality from coronary and cerebral thrombosis in winter. Br Med J (Clin Res Ed) (1984) 4.00
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes (1998) 3.55
Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation (2001) 2.82
Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab (2000) 2.43
The anti-coronary club. A dietary approach to the prevention of coronary heart disease--a seven-year report. Am J Public Health Nations Health (1966) 2.42
Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study) BMJ (1996) 2.42
The relationship of HIV prevalence in pregnant women to that in women of reproductive age: a validated method for adjustment. AIDS (1998) 2.34
Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia (1996) 2.15
Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia (2001) 2.12
Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab (1989) 2.07
Cold-induced increases in erythrocyte count, plasma cholesterol and plasma fibrinogen of elderly people without a comparable rise in protein C or factor X. Clin Sci (Lond) (1994) 2.04
Experts debate merits of 1-day opiate detoxification under anesthesia. JAMA (1997) 2.04
New approaches for detecting and curtailing foodborne microbial infections. JAMA (1997) 2.03
Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabet Med (2008) 1.91
The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med (2004) 1.89
Myopathy and malignant hyperpyrexia. Lancet (1970) 1.87
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care (1999) 1.86
Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care (2001) 1.84
Estimation of weights and tensions and apparent involvement of a "sense of effort". Exp Neurol (1974) 1.67
Pentagon-funded research takes aim at agents of biological warfare. JAMA (1997) 1.65
Social deprivation and mortality in adults with diabetes mellitus. Diabet Med (1998) 1.64
Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria. JAMA (1996) 1.63
Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med (1998) 1.61
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest (2001) 1.59
Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea. Diabetes Obes Metab (2008) 1.58
Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord (1996) 1.58
Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia (2001) 1.56
Pre-hospital transportation in Western countries for Ebola patients, comparison of guidelines. Intensive Care Med (2015) 1.54
Public health experts take aim at a moving target: foodborne infections. JAMA (1997) 1.52
Living near a lead smelter: an environmental health risk assessment in Boolaroo and Argenton, New South Wales. Aust J Public Health (1993) 1.51
A "safer" cigarette? Prove it, say critics. JAMA (2000) 1.50
Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. Ophthalmology (1997) 1.50
Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol (2001) 1.48
Education and employment for young people with diabetes. Diabet Med (1993) 1.47
Disease progression and survival in HIV-1-infected Africans in London. AIDS (1998) 1.47
Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements? Metabolism (1995) 1.44
Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab (1999) 1.43
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia (2007) 1.40
Mosaic vessels shed cancer clues by the million. Lancet Oncol (2001) 1.39
Cardiogenic brain embolism: role of anticoagulants. Aust N Z J Med (1989) 1.39
Medical, mental health communities mobilize to cope with terror's psychological aftermath. JAMA (2001) 1.39
Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors. N Engl J Med (1978) 1.37
The effect of dislike of school on risk of teenage pregnancy: testing of hypotheses using longitudinal data from a randomised trial of sex education. J Epidemiol Community Health (2005) 1.35
Deficiency of the human mitochondrial transcription factor h-mtTFA in infantile mitochondrial myopathy is associated with mtDNA depletion. Hum Mol Genet (1994) 1.35
Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1997) 1.34
Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia (2001) 1.33
Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesis. Neurology (1996) 1.33
Evaluation of a tanned red cell technique for thyroid microsomal antibodies. J Clin Pathol (1973) 1.27
A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer. Ann Oncol (2011) 1.25
Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med (2002) 1.24
Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia (2000) 1.23
Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia (2006) 1.22
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. J Clin Oncol (1999) 1.21
Sexual behaviour, condom use, and disclosure of HIV status in HIV infected heterosexual individuals attending an inner London HIV clinic. Sex Transm Infect (2006) 1.20
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia (1996) 1.17
Noncompliance may cause half of antihypertensive drug "failures". JAMA (1999) 1.15
Body mass index and the risk of mortality in type II diabetic patients from Verona. Int J Obes Relat Metab Disord (2003) 1.15
Serum uric acid and related factors in 500 hospitalized subjects. Metabolism (1996) 1.14
Does the UK government's teenage pregnancy strategy deal with the correct risk factors? Findings from a secondary analysis of data from a randomised trial of sex education and their implications for policy. J Epidemiol Community Health (2007) 1.14
Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance. Diabetes Care (1997) 1.14
Combined modalities of resistance in etoposide-resistant human KB cell lines. Cancer Res (1988) 1.14
ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care (1999) 1.14
A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: Causes and death rates. Diabetologia (1990) 1.13
Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care (2000) 1.11
Plasma triglyceride and fatty acid metabolism in diabetes mellitus. Eur J Clin Invest (1972) 1.11
The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group. Diabetologia (1999) 1.11
Capture-recapture method in the epidemiology of type 2 diabetes: a contribution from the Verona Diabetes Study. Diabetes Care (2000) 1.11
Patient pretenders weave tangled "Web" of deceit. JAMA (1998) 1.11
Glycemic index in the diet of European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum lipids. Am J Clin Nutr (2001) 1.10
Regulation of insulin receptors in normal and abnormal physiology in humans. Adv Intern Med (1979) 1.10
Automated alignment and sizing of myocardial stress and rest scans to three-dimensional normal templates using an image registration algorithm. J Nucl Med (1995) 1.10
Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes (2000) 1.10
Improvement in paraplegia in vertebral Paget's disease treated with calcitonin. Br Med J (1976) 1.06
Attending the diabetes center is associated with increased 5-year survival probability of diabetic patients: the Verona Diabetes Study. Diabetes Care (1996) 1.06
The insulin resistance of acromegaly: evidence for two alterations in the insulin receptor on circulating monocytes. J Clin Endocrinol Metab (1979) 1.05
Influence of family type and parenting behaviours on teenage sexual behaviour and conceptions. J Epidemiol Community Health (2006) 1.05
Former addicts face barriers to treatment for HCV. JAMA (2001) 1.05
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia (2004) 1.05
The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab (1996) 1.05
Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP. J Clin Oncol (1998) 1.04
Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications. Diabetes Care (2001) 1.03
Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord (2003) 1.02
Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int J Obes Relat Metab Disord (1995) 1.01
Membranous glomerulonephritis and Landry-Guillain-Barre syndrome. Am J Kidney Dis (1986) 1.01
Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. Diabetes (1982) 1.01
AIDS researchers target poor adherence. JAMA (1999) 1.00
Prostate cancer gene hunters track their quarry. JAMA (1996) 1.00
Rural HIV/AIDS in the United States: studies suggest presence, no rampant spread. JAMA (2000) 1.00
Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). Diabetes Nutr Metab (2004) 1.00
Eosinophilic meningitis due to Angiostrongylus cantonensis. West J Med (1993) 0.99
Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. J Clin Endocrinol Metab (1983) 0.99
Home treatment with Elaprase and Naglazyme is safe in patients with mucopolysaccharidoses types II and VI, respectively. J Inherit Metab Dis (2008) 0.99
Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol (2000) 0.99
Elevated plasma levels of soluble receptors of TNF-alpha and their association with smoking and microvascular complications in young adults with type 1 diabetes. J Clin Endocrinol Metab (2001) 0.98
Insulin resistance in Cushing's syndrome. J Clin Endocrinol Metab (1983) 0.98
Variants and haplotypes of TCF7L2 are associated with β-cell function in patients with newly diagnosed type 2 diabetes: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 1. J Clin Endocrinol Metab (2010) 0.98